CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 2.5: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.89%
Annual Rate
CNY 1.00Paid semi-annual
Payout Ratio
227.3%High
Payback Period
34.7 yr
Last Ex-Dividend
Jun 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.75BCNY409.90M · vs all stocks (USD)
Revenue (TTM)
686.70MCNY102.47M · vs all stocks (USD)
Profit Margin
-1.40%vs Medical Instruments & Supplies peers
Beta
0.3920xvs all stocks
52-Week Change
13.56%vs all stocks
Forward Annual Dividend Yield
2.89%vs all stocks
Market Capitalization
2.75BCNY409.90M · vs all stocks (USD)
Enterprise Value
3.00BCNY447.00M · vs all stocks (USD)
Forward P/E
10.41xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
4.00xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.62xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.36xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
23.41xvs Medical Instruments & Supplies peers
Gross Margin
45.71%vs Medical Instruments & Supplies peers
Profit Margin
-1.40%vs Medical Instruments & Supplies peers
Operating Margin
1.78%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.82%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-0.95%vs Medical Instruments & Supplies peers
Revenue (TTM)
686.70MCNY102.47M · vs all stocks (USD)
Revenue per Share (TTM)
8.43CNYUpdated Sep 21, 2026Quarterly Revenue Growth
35.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
314.58MCNY46.94M · vs all stocks (USD)
EBITDA (TTM)
71.45MCNY10.66M · vs all stocks (USD)
Net Income (TTM)
-9.59MCNY-1.43M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
48.10%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
53.58MCNY8.00M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-387.21MCNY-57.78M · vs all stocks (USD)
Forward Annual Dividend Rate
1.00CNYUpdated Sep 21, 2026Forward Annual Dividend Yield
2.89%vs all stocks
Trailing Annual Dividend Rate
1.00CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
2.89%vs all stocks
Payout Ratio
227.27%vs Medical Instruments & Supplies peers
Revenue
575.76MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
328.33MCNYFY2025 · Dec 31, 2025Gross Profit
247.43MCNYFY2025 · Dec 31, 2025Operating Income
48.30MCNY7.21M · vs all stocks (USD)
Pre-tax Income
-10.78MCNYFY2025 · Dec 31, 2025Income Tax Expense
5.44MCNYFY2025 · Dec 31, 2025Net Income
-16.22MCNYFY2025 · Dec 31, 2025EBIT
2.40MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
71.45MCNYFY2025 · Dec 31, 2025Research & Development
56.93MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
53.12MCNYFY2025 · Dec 31, 2025Other Operating Expenses
10.66MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
15.05MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
13.18MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1999CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1999CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
81.12MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
81.12MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-16.22MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00CNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-76.78MCNYFY2025 · Dec 31, 2025Free Cash Flow
-381.59MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
280.39MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-16.22MCNYFY2025 · Dec 31, 2025Other Non-cash Items
28.48MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-70.97MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.07MCNYFY2025 · Dec 31, 2025Capital Expenditures
-304.80MCNYFY2025 · Dec 31, 2025Net Acquisitions
-106.54MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.18BCNYFY2025 · Dec 31, 2025Sale of Investments
1.32BCNYFY2025 · Dec 31, 2025Other Investing Activity
-63.81MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-341.82MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
461.62MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-181.54MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-41.58MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.72MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
235.79MCNYFY2025 · Dec 31, 2025Shares Outstanding
81.61MSharesUpdated Sep 21, 2026Float Shares
22.63MSharesUpdated Sep 21, 2026% Held by Insiders
72.03%vs all stocks
% Held by Institutions
4.55%vs all stocks
Total Cash (MRQ)
598.84MCNY89.36M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.56CNYUpdated Sep 21, 2026Total Debt (MRQ)
926.63MCNY138.27M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.9104xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.33xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
12.84CNYUpdated Sep 21, 2026Total Assets
2.07BCNY308.37M · vs all stocks (USD)
Total Current Assets
928.95MCNYFY2025 · Dec 31, 2025Total Liabilities
920.15MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.14BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
355.13MCNYFY2025 · Dec 31, 2025Total Current Liabilities
565.03MCNYFY2025 · Dec 31, 2025Cash
417.73MCNYFY2025 · Dec 31, 2025Cash Equivalents
19.13MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
436.86MCNYFY2025 · Dec 31, 2025Other Short-term Investments
155.83MCNYFY2025 · Dec 31, 2025Accounts Receivable
106.87MCNYFY2025 · Dec 31, 2025Inventory
119.26MCNYFY2025 · Dec 31, 2025Accounts Payable
160.65MCNYFY2025 · Dec 31, 2025Short-term Debt
330.32MCNYFY2025 · Dec 31, 2025Other Current Liabilities
10.46MCNYFY2025 · Dec 31, 2025Long-term Debt
332.10MCNYFY2025 · Dec 31, 2025Common Stock (Book)
58.95MCNYFY2025 · Dec 31, 2025Retained Earnings
315.95MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.15BCNY171.06M · vs all stocks (USD)
Treasury Stock
57.66MCNYFY2025 · Dec 31, 202552-Week Low
28.72CNYUpdated Sep 21, 202652-Week High
48.56CNYUpdated Sep 21, 202652-Week Change
13.56%vs all stocks
Beta
0.3920xvs all stocks
50-Day MA
33.53CNYUpdated Sep 21, 2026200-Day MA
37.95CNYUpdated Sep 21, 2026Avg 10-Day Volume
526.51KSharesUpdated Sep 21, 2026Avg 30-Day Volume
747.53KSharesUpdated Sep 21, 2026Diluted EPS (TTM)
-0.0900CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.46Profit Margin: -0.01
Financial Health
Altman Z-Score 2.5: grey zoneSignificant
Altman Z-Score: 2.50
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Nanjing Aolian Ae&Ea Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Comnav Technology Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Hangzhou Juheshun New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Suzhou Future Electrical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Truly International Holdings Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Senba Sensing Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Dongwoon Anatech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Sunfly Intelligent Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Dezhou United Petroleum Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule
Rallis India Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow